Pharma Veterans

Bayer Hierarchy Structure Shakeup – Asrar Qureshi’s Blog Post #943 Dear Colleagues! This is Asrar Qureshi’s Blog Post #943 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Bayer CEO - Bill Anderson Brief History of Bayer Bayer is a German chemical and pharmaceutical company which was founded in 1863 by Friedrich Bayer, who was a chemical salesman, and Johann Friedrich, who owned a dye company. The company enjoyed rapid growth, and it was transformed into a joint stock company in 1881. Between 1881 and 1914, Bayer developed into a company with international operations. By 1913, over 80 percent revenues came from exports. Pharmaceutical department and more production sites were added. And then World War I started causing major disruption in exports. After WWI ended, German companies could not regain their previous markets and there...

New Drugs Approvals – Asrar Qureshi’s Blog Post #929 Dear Colleagues! This is Asrar Qureshi’s Blog Post #929 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Mikhail Nilov Credit: Pavel Danilyuk Credit: Polina Tankilevitch Periodically, I gather information and write a blog post about approval of new drugs in the USA, because it leads in the research, discovery, and commercialization of new, research products. Even if a pharmaceutical product is first registered in Europe, it is inevitably applied to USFDA for approval. USA also leads because it is the single largest market in the global pharma market. US accounts for about 47% of the world pharmaceutical market which is currently estimated to be about US$ 1.2 trillion. You can have an idea of the size.  The list of new drugs/ newer uses of existing drugs is given bel...

Implications of Pharma MNCs Exit – Asrar Qureshi’s Blog Post #824 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #824 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Anna Tarazevich Photo Credit: cottonbro studio Photo Credit: Tima Miroshnichenko When I joined Pharma industry in 1975, there were around 50 multinational pharmaceutical companies in the market; the number of local companies would be around 100. The market was dominated by MNCs with over 80% market share. Presently, the number of MNCs has decreased to under 20. Some merged, while others rolled back operations. Most notable exits have been Roche, MSD, Merck Marker, Pfizer, Eli Lilly, Janssen, Fresenius Kabi, Sanofi, and Bayer.  Pharma MNCs are not the ...